Richard L Monroe, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 925 N Western Ave, West Peoria, IL 61604 Phone: 309-676-4421 |
Andrew B Kurz, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 221 N Western Ave, West Peoria, IL 61604 Phone: 309-673-0665 |
Dr. Keith R Fuentes, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 221 N Western Ave, West Peoria, IL 61604 Phone: 309-673-0665 Fax: 309-673-3593 |
Isaac Ibrahim Boktor Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 221 N Western Ave, West Peoria, IL 61604 Phone: 309-673-0665 |
News Archive
A study conducted by German researchers has shown that the neurological symptoms observed in some patients with coronavirus disease 2019 (COVID-19) may be caused by autoantibodies targeting the brain.
There is more to fighting infection than just clearing the body of pathogens. As important as resisting infection, is limiting damage to the host's tissue caused, very frequently, by toxins produced by pathogens or by components of the host immune response that clears those pathogens.
Researchers from Clinica Luganese Moncucco and Bellinzona Regional Hospital in Switzerland investigated the prevalence of swelling disorders in severely ill COVID-19 patients and reported their results in a paper posted to the medRxiv* preprint server.
Endo Pharmaceuticals today announced actions designed to advance the company's leadership and growth in pain management, including an agreement to acquire all outstanding shares of Penwest Pharmaceuticals for $5.00 in cash per share, or an estimated enterprise value of approximately $144 million at the time of deal close. Penwest has been working with Endo since 1997 on the development and commercialization of OPANA® ER and receives a royalty stream on net sales of the product.
› Verified 4 days ago